Product
TY-302
1 clinical trial
2 indications
Indication
Breast CancerIndication
Solid TumorClinical trial
A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of TY-302 Capsules in Patients With Advanced Solid Tumors in ChinaStatus: , Estimated PCD: 2023-05-01